Finance

Beta
Lists
300723:SHE
ApicHope Pharmaceutical Group Co Ltd
CNÂ¥37.58
-3.57%
(-1.39) 1D
Jun 5, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300723...
Open
CNÂ¥39.86
High
CNÂ¥40.50
Low
CNÂ¥37.37
Mkt. cap
16.97B
Avg. vol.
19.42M
Volume
14.08M
P/E ratio
84.82
52-wk high
CNÂ¥81.48
52-wk low
CNÂ¥29.31
EPS
CNÂ¥0.44
Shares outstanding
451.69M
No. of employees
1K
Open
CNÂ¥39.86
High
CNÂ¥40.50
Low
CNÂ¥37.37
Mkt. cap
16.97B
Avg. vol.
19.42M
Volume
14.08M
P/E ratio
84.82
52-wk high
CNÂ¥81.48
52-wk low
CNÂ¥29.31
EPS
CNÂ¥0.44
Shares outstanding
451.69M
No. of employees
1K
News stories
From sources across the web
About ApicHope Pharmaceutical Group Co Ltd
CEO-
Employees1.29K
FoundedFeb 4, 2002
Headquarters-
SectorPharmaceutical industry
Websiteapichope.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
206.84M
230.21M
118.27M
385.47M
Cost of goods sold
96.72M
88.31M
84.90M
130.76M
Cost of revenue
96.72M
88.31M
84.90M
130.76M
Research and development expenses
47.09M
21.84M
51.68M
38.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.88M
170.98M
121.51M
207.76M
Operating expense
237.15M
199.25M
171.41M
231.13M
Total operating expenses
333.87M
287.56M
256.31M
361.89M
Operating income
-127.03M
-57.36M
-138.04M
23.58M
Other non operating income
42.13K
43.29M
-44.07M
-1.07M
EBT including unusual items
-157.76M
-58.10M
-213.72M
592.69M
EBT excluding unusual items
-155.76M
-20.64M
-209.76M
592.77M
Income tax expense
-26.54M
7.32M
-10.45M
75.58K
Effective tax rate
16.83%
-12.61%
4.89%
0.01%
Other operating expenses
3.01M
6.48M
2.91M
-14.68M
Net income
-130.13M
-62.54M
-201.71M
594.38M
Net profit margin
-62.91%
-27.17%
-170.56%
154.20%
Earnings per share
-
-
-
-
Interest and investment income
-
7.28M
-
586.15M
Interest expense
-28.76M
-13.87M
-27.55M
-15.89M
Net interest expenses
-28.76M
-6.59M
-27.55M
570.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.71M
-12.88M
-90.05M
71.57M
Gain or loss from assets sale
-81.68K
81.68K
1.16M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer